Pradefovir
Pradefovir (Remofovir) is a liver-targeted prodrug of adefovir developed for chronic hepatitis B virus (HBV) research. It is metabolically activated in the liver to the active reverse transcriptase inhibitor PMEA. This compound is utilized in both in vitro enzymatic studies and in vivo models of HBV infection to investigate targeted antiviral therapies.
Product Specifications
CAS Number
625095-60-5
Product Name Alternative
Pradefovir, Remofovir, MB6866, MB-6866, MB06866, MB-06866, MB 6866, MB 06866, HBV, ICN20013, ICN-20013, ICN-2001-3, ICN 20013
Field of Research
Infectious Disease & Virology, Metabolism Research
Purity
97.50% (May vary between batches)
Solubility
DMSO:Soluble
Smiles
C (COCP1 (=O) O[C@@H] (CCO1) C2=CC (Cl) =CC=C2) N3C=4C (N=C3) =C (N) N=CN4
Molecular Formula
C17H19ClN5O4P
Molecular Weight
423.79
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1299502 Inquire
Recombinant Salmonella typhimurium Valine--tRNA ligase (valS), partial
Sign In for Pricing
View Details 
MBS7022986-01 0.02 mg
Recombinant Synechococcus sp. NAD(P)H-quinone oxidoreductase subunit 3 (ndhC)
Sign In for Pricing
View Details MBS7022986-02 0.1 mg
Recombinant Synechococcus sp. NAD(P)H-quinone oxidoreductase subunit 3 (ndhC)
Sign In for Pricing
View Details MBS7022986-03 5x 0.1 mg
Recombinant Synechococcus sp. NAD(P)H-quinone oxidoreductase subunit 3 (ndhC)
Sign In for Pricing
View Details